Simultaneous knockdown of multiple ligands of innate receptor NKG2D prevents natural killer cell-mediated fulminant hepatitis in mice

Hepatology

Volumn 57, Issue 1, 2013, Pages 277-288

  Huang, Mei ^a,b   Sun, Rui ^a,b   Wei, Haiming ^a,b   Tian, Zhigang ^a,b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

H60 PROTEIN; LIGAND; MESSENGER RNA; MULT1 PROTEIN; NATURAL KILLER CELL RECEPTOR NKG2D; RAE1 PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; DOWN REGULATION; HEPATITIS; HYDRODYNAMICS; IN VIVO STUDY; LIVER CELL; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA INTERFERENCE;

ANIMALS; GENE KNOCKDOWN TECHNIQUES; GENETIC VECTORS; HEPATITIS, ANIMAL; HEPATOCYTES; HUMANS; KILLER CELLS, NATURAL; LIGANDS; MALE; MICE; MICE, INBRED C57BL; NIH 3T3 CELLS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84872134939     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25959     Document Type: Article

References (34)

1. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285: 727-729.
2. Wu J, Song Y, Bakker AB, Bauer S, Spies T, Lanier LL, et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 1999; 285: 730-732.
3. Vilarinho S, Ogasawara K, Nishimura S, Lanier LL, Baron JL. Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus. Proc Natl Acad Sci U S A 2007; 104: 18187-18192.
4. Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, Filler R, et al. Regulation of cutaneous malignancy by gammadelta T cells. Science 2001; 294: 605-609.
5. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A 1996; 93: 12445-12450.
6. Sutherland CL, Chalupny NJ, Cosman D. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions. Immunol Rev 2001; 181: 185-192.
7. Cosman D, Müllberg J, Sutherland CL, Chin W, Armitage R, Fanslow W, et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 2001; 14: 123-133.
8. Cerwenka A, Bakker AB, McClanahan T, Wagner J, Wu J, Phillips JH, et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 2000; 12: 721-727.
9. Carayannopoulos LN, Naidenko OV, Kinder J, Ho EL, Fremont DH, Yokoyama WM. Ligands for murine NKG2D display heterogeneous binding behavior. Eur J Immunol 2002; 32: 597-605.
10. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 2000; 1: 119-126.
11. Gasser S, Orsulic S, Brown EJ, Raulet DH. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005; 436: 1186-1190.
12. Nausch N, Cerwenka A. NKG2D ligands in tumor immunity. Oncogene 2008; 27: 5944-5958.
13. Sutherland CL, Rabinovich B, Chalupny NJ, Brawand P, Miller R, Cosman D. ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15. Blood 2006; 108: 1313-1319.
14. Champsaur M, Lanier LL. Effect of NKG2D ligand expression on host immune responses. Immunol Rev 2010; 235: 267-285.
15. Haworth O, Cernadas M, Levy BD. NK cells are effectors for resolvin E1 in the timely resolution of allergic airway inflammation. J Immunol 2011; 186: 6129-6135.
16. Chen GE, Wu H, Ma J, Chadban SJ, Sharland A. Toll-like receptor 4 engagement contributes to expression of NKG2D ligands by renal tubular epithelial cells. Nephrol Dial Transplant 2011; 26: 3873-3881.
17. Kjellev S, Haase C, Lundsgaard D, Ursø B, Tornehave D, Markholst H. Inhibition of NKG2D receptor function by antibody therapy attenuates transfer-induced colitis in SCID mice. Eur J Immunol 2007; 37: 1397-1406.
18. Ito Y, Kanai T, Totsuka T, Okamoto R, Tsuchiya K, Nemoto Y, et al. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis. Am J Physiol Gastrointest Liver Physiol 2008; 294: G199-G207.
19. Andersson AK, Sumariwalla PF, McCann FE, Amjadi P, Chang C, McNamee K, et al. Blockade of NKG2D ameliorates disease in collagen-induced arthritic mice: a potential pathogenic role in chronic inflammatory arthritis. Arthritis Rheum 2011; 63: 2617-2629.
20. Chen Y, Wei H, Sun R, Dong Z, Zhang J, Tian Z. Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells. HEPATOLOGY 2007; 46: 706-715.
21. Cheng M, Ma J, Chen Y, Zhang J, Zhao W, Wei H, et al. Establishment, characterization and successful adaptive therapy against human tumors of NKG cell, a new human NK cell line. Cell Transplant 2011;10.3727/096368911X580536.
22. Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004; 294: 15-22.
23. Hou X, Zhou R, Wei H, et al. NKG2D-retinoic acid early inducible-1 recognition between natural killer cells and Kupffer cells in a novel murine natural killer cell-dependent fulminant hepatitis. HEPATOLOGY 2009; 49: 940-949.
24. Miyagishi M, Taira K. Strategies for generation of an siRNA expression library directed against the human genome. Oligonucleotides 2003; 13: 325-333.
25. Miyagishi M, Matsumoto S, Taira K. Generation of an shRNAi expression library against the whole human transcripts. Virus Res 2004; 102: 117-124.
26. Kobayashi N, Nishikawa M, Hirata K, et al. Hydrodynamics-based procedure involves transient hyperpermeability in the hepatic cellular membrane: implication of a nonspecific process in efficient intracellular gene delivery. J Gene Med 2004; 6: 584-592.
27. Song YK, Liu F, Zhang G, et al. [5] Hydrodynamics-based transfection: simple and efficient method for introducing and expressing transgenes in animals by intravenous injection of DNA. In: Phillips MI, ed. Methods in Enzymology. Volume 346. Orlando, FL: Academic Press; 2002: 92-105.
28. Andrianaivo F, Lecocq M, Wattiaux-De Coninck S, et al. Hydrodynamics-based transfection of the liver: entrance into hepatocytes of DNA that causes expression takes place very early after injection. J Gene Med 2004; 6: 877-883.
29. Wilson JM. Adenoviruses as gene-delivery vehicles. N Engl J Med 1996; 334: 1185-1187.
30. Wallach D. Regulation of susceptibility to natural killer cells' cytotoxicity and regulation of HLA synthesis: differing efficacies of alpha, beta, and gamma interferons. J Interferon Res 1982; 2: 329-338.
31. Karre K. NK cells, MHC class I molecules and the missing self. Scand J Immunol 2002; 55: 221-228.
32. Samarakoon A, Chu H, Malarkannan S. Murine NKG2D ligands: "double, double toil and trouble." Mol Immunol 2009; 46: 1011-1019.
33. Davidson BL, McCray PB Jr. Current prospects for RNA interference-based therapies. Nat Rev Genet 2011; 12: 329-340.
34. Verhoeven DH, de Hooge AS, Mooiman EC, Santos SJ, ten Dam MM, Gelderblom H, et al. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways. Mol Immunol 2008; 45: 3917-25.